Outset Medical to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- None.
- None.
A live and archived webcast of the presentation will be available on the “Investors” section of the Outset website at https://investors.outsetmedical.com/.
About Outset Medical, Inc.
Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo® Hemodialysis System, FDA cleared for use from the hospital to the home, represents a significant technological advancement that transforms the dialysis experience for patients and operationally simplifies it for providers. Tablo serves as a single enterprise solution that can be utilized across the continuum of care, allowing dialysis to be delivered anytime, anywhere and by anyone. The integration of water purification and on-demand dialysate production enables Tablo to serve as a dialysis clinic on wheels, with 2-way wireless data transmission and a proprietary data analytics platform powering a new holistic approach to dialysis care. Tablo is a registered trademark of Outset Medical, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240103380883/en/
Jim Mazzola
Vice President, Investor Relations
jmazzola@outsetmedical.com
Source: Outset Medical, Inc.
FAQ
What is the company name presenting at the J.P. Morgan Healthcare conference on January 8, 2024?
What is the ticker symbol of the company presenting at the J.P. Morgan Healthcare conference on January 8, 2024?
When will the presentation take place at the J.P. Morgan Healthcare conference?